» Articles » PMID: 6628520

Amitriptyline and Ethanol: Pharmacokinetic and Pharmacodynamic Interaction

Overview
Specialty Pharmacology
Date 1983 Jan 1
PMID 6628520
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Amitriptyline has clinically important interactions with ethanol. Five healthy volunteers received 25 mg of amitriptyline orally, preceded by one hour and followed for eight hours by oral ethanol (or juice), dosed to achieve and maintain blood ethanol concentrations of 800 mg/l. In the presence of ethanol, amitriptyline free plasma concentrations were increased by a logarithmic mean of 204%, 186% and 127% at 1.5, 2, and 2.5 h, respectively, and amitriptyline free AUC0-8h was increased by 48% +/- 13% (means +/- SEM) (t = 5.21, p less than 0.01). Nortriptyline total AUC0-8h was increased by 26.6% +/- 12% (means +/- SEM) (t = 2.21, p less than 0.09). At the time of peak amitriptyline plasma concentrations, mean postural sway was increased over baseline by 92% with, and 2% without ethanol; likewise, mean short term memory (word recall) was decreased over baseline by 71% with, and 37% without ethanol. Ethanol increases free amitriptyline plasma concentrations most dramatically during the period of drug absorption; this is due to a decrease in amitriptyline hepatic clearance, resulting in decreased first-pass extraction. Together with the pharmacodynamic interaction, the kinetic changes provide a rationale for the toxicity of this combination and its deleterious effects on psychomotor skills.

Citing Articles

Non-additivity of the functional properties of individual P450 species and its manifestation in the effects of alcohol consumption on the metabolism of ketamine and amitriptyline.

Ponraj K, Gaither K, Singh D, Davydova N, Zhao M, Luo S Biochem Pharmacol. 2024; 230(Pt 1):116569.

PMID: 39393643 PMC: 11609013. DOI: 10.1016/j.bcp.2024.116569.


The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice.

Marciano G, Vocca C, Evangelista M, Palleria C, Muraca L, Galati C Pharmaceutics. 2023; 15(4).

PMID: 37111650 PMC: 10144480. DOI: 10.3390/pharmaceutics15041165.


Toward a systems approach to cytochrome P450 ensemble: interactions of CYP2E1 with other P450 species and their impact on CYP1A2.

Davydova N, Dangi B, Maldonado M, Vavilov N, Zgoda V, Davydov D Biochem J. 2019; 476(23):3661-3685.

PMID: 31750875 PMC: 7085345. DOI: 10.1042/BCJ20190532.


Alcohol Interaction with Cocaine, Methamphetamine, Opioids, Nicotine, Cannabis, and γ-Hydroxybutyric Acid.

Singh A Biomedicines. 2019; 7(1).

PMID: 30866524 PMC: 6466217. DOI: 10.3390/biomedicines7010016.


Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals.

Tylutki Z, Mendyk A, Polak S J Pharmacokinet Pharmacodyn. 2018; 45(5):663-677.

PMID: 29943290 PMC: 6182726. DOI: 10.1007/s10928-018-9597-6.


References
1.
Risch S, Huey L, Janowsky D . Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II. J Clin Psychiatry. 1979; 40(2):58-69. View

2.
Mezey E . Ethanol metabolism and ethanol-drug interactions. Biochem Pharmacol. 1976; 25(8):869-75. DOI: 10.1016/0006-2952(76)90305-1. View

3.
LOCKETT M, Milner G . COMBINING ANTIDEPRESSANT DRUGS. Br Med J. 1965; 1(5439):921. PMC: 2165576. DOI: 10.1136/bmj.1.5439.921-a. View

4.
Cooper T, Allen D, Simpson G . A sensitive method for the determination of amitriptyline and nortriptyline in human plasma. Psychopharmacol Commun. 1976; 2(2):105-16. View

5.
Hudson C . Tricyclic antidepressants and alcoholic blackouts. J Nerv Ment Dis. 1981; 169(6):381-2. DOI: 10.1097/00005053-198106000-00008. View